X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2638) 2638
Newsletter (27) 27
Book / eBook (6) 6
Magazine Article (5) 5
Dissertation (4) 4
Book Chapter (3) 3
Web Resource (2) 2
Publication (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1874) 1874
life sciences & biomedicine (1544) 1544
humans (1480) 1480
animals (993) 993
diphosphonates - pharmacology (893) 893
diphosphonates - chemistry (816) 816
diphosphonates - therapeutic use (724) 724
female (710) 710
male (596) 596
bisphosphonates (514) 514
diphosphonates (491) 491
chemistry (438) 438
physical sciences (410) 410
osteoporosis (401) 401
diphosphonates - administration & dosage (382) 382
biochemistry & molecular biology (364) 364
mice (342) 342
bisphosphonate (337) 337
rats (327) 327
pharmacology & pharmacy (320) 320
endocrinology & metabolism (318) 318
middle aged (314) 314
aged (293) 293
bone density conservation agents - therapeutic use (286) 286
zoledronic acid (280) 280
analysis (263) 263
phosphonates (260) 260
diphosphonates - adverse effects (238) 238
research (228) 228
orthopedics (225) 225
imidazoles - pharmacology (224) 224
cell biology (223) 223
bone density conservation agents - pharmacology (203) 203
bones (203) 203
oncology (195) 195
cell line, tumor (187) 187
bone density - drug effects (177) 177
bone density conservation agents - administration & dosage (175) 175
osteoporosis - drug therapy (174) 174
diphosphonates - metabolism (170) 170
imidazoles - therapeutic use (169) 169
drug therapy (168) 168
adult (165) 165
cancer (156) 156
dose-response relationship, drug (156) 156
bone neoplasms - secondary (155) 155
diphosphonates - chemical synthesis (155) 155
endocrinology (154) 154
care and treatment (153) 153
technology (152) 152
chemistry, multidisciplinary (151) 151
molecular structure (149) 149
bone neoplasms - drug therapy (147) 147
structure-activity relationship (147) 147
diphosphonates - pharmacokinetics (145) 145
imidazoles - administration & dosage (145) 145
bone density conservation agents - adverse effects (144) 144
bone and bones - metabolism (142) 142
bone resorption (141) 141
life sciences (141) 141
time factors (141) 141
treatment outcome (140) 140
biochemistry, general (139) 139
bone and bones - drug effects (138) 138
cells, cultured (137) 137
abridged index medicus (133) 133
osteoclasts - drug effects (133) 133
dentistry (132) 132
medicine & public health (132) 132
health aspects (128) 128
aged, 80 and over (126) 126
models, molecular (125) 125
bone density (123) 123
materials science (123) 123
bone density conservation agents - chemistry (120) 120
risk factors (118) 118
fractures (117) 117
apoptosis (113) 113
imidazoles - chemistry (110) 110
apoptosis - drug effects (109) 109
chemistry, medicinal (109) 109
pamidronate (109) 109
rats, sprague-dawley (106) 106
antineoplastic agents - pharmacology (104) 104
enzyme inhibitors - pharmacology (104) 104
cell proliferation - drug effects (102) 102
kinetics (102) 102
metastasis (101) 101
osteoporosis, postmenopausal - drug therapy (100) 100
bone resorption - drug therapy (99) 99
breast cancer (97) 97
chemistry, inorganic & nuclear (95) 95
cell line (91) 91
alendronate (90) 90
materials science, biomaterials (89) 89
medicine, research & experimental (89) 89
research & experimental medicine (89) 89
phosphates (88) 88
chemical properties (87) 87
rheumatology (87) 87
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2649) 2649
Japanese (28) 28
German (22) 22
French (12) 12
Chinese (8) 8
Spanish (6) 6
Polish (4) 4
Russian (4) 4
Italian (3) 3
Portuguese (2) 2
Danish (1) 1
Norwegian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of controlled release, ISSN 0168-3659, 08/2016, Volume 235, pp. 365 - 378
Osteoinduction can be enhanced by combining scaffolds with bone morphogenic protein-2 (BMP-2). However, BMP's are known to also cause bone resorption. This can... 
Zoledronic acid | Bone tissue engineering | Biomaterial | Biocomposite | Cryogel | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Fibroins - chemistry | Cryogels - chemistry | Alkaline Phosphatase - metabolism | Imidazoles - chemistry | Drug Carriers - administration & dosage | Imidazoles - administration & dosage | Bone Morphogenetic Protein 2 - chemistry | Male | Glass - chemistry | Drug Carriers - chemistry | Cryogels - administration & dosage | Bone Morphogenetic Protein 2 - administration & dosage | Cell Line | Osteogenesis - drug effects | Recombinant Proteins - chemistry | Durapatite - chemistry | Bone Regeneration | Diphosphonates - administration & dosage | Rats, Sprague-Dawley | Recombinant Proteins - administration & dosage | Animals | Chitosan - chemistry | Sepharose - chemistry | Diphosphonates - chemistry | Cell Proliferation - drug effects | Mice | Porosity | Analysis | Phosphatases | Biological products | Tissue engineering | Index Medicus | Biomaterials Science | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinteknik | Medicinsk bioteknologi | Biomaterialvetenskap | Teknik | Medical Biotechnology | Engineering and Technology | Medical Engineering | Medical Materials | Medicinsk material- och protesteknik
Journal Article
Biomaterials, ISSN 0142-9612, 03/2016, Volume 82, pp. 178 - 193
Abstract Zoledronate (Zol) is a third-generation bisphosphonate that is widely used as an anti-resorptive agent for the treatment of cancer bone metastasis.... 
Advanced Basic Science | Dentistry | Folate-targeted nanoscale metal-organic frameworks | Chemotherapy | Drug delivery | Zoledronate | Cancer | Engineering | Materials Science | Technology | Engineering, Biomedical | Materials Science, Biomaterials | Science & Technology | Nanocomposites - chemistry | Apoptosis - drug effects | Humans | Imidazoles - chemistry | Imidazoles - administration & dosage | Delayed-Action Preparations - chemistry | Antineoplastic Agents - administration & dosage | Calcium - chemistry | Nanocapsules - chemistry | Delayed-Action Preparations - administration & dosage | Neoplasms, Experimental - pathology | Metals - chemistry | Bone Density Conservation Agents | Cell Survival - drug effects | Folic Acid - chemistry | Organic Chemicals - chemistry | Treatment Outcome | Diphosphonates - administration & dosage | Zoledronic Acid | Antineoplastic Agents - chemistry | Folic Acid - pharmacokinetics | Diphosphonates - chemistry | Cell Line, Tumor | Neoplasms, Experimental - drug therapy | Hydrogen-Ion Concentration | Drugs | Drug delivery systems | Care and treatment | Phosphonates | Lung cancer, Non-small cell | Polyols | Folic acid | Vehicles | Analysis | Health aspects | Prostate cancer | Nanotechnology | Index Medicus | Polyethylene glycol | Bones | Nanostructure | Prostate | Metal-organic frameworks | Apoptosis | Tumors | Anticancer properties
Journal Article
Bioconjugate chemistry, ISSN 1043-1802, 02/2016, Volume 27, Issue 2, pp. 319 - 328
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 01/2006, Volume 128, Issue 2, pp. 620 - 628
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 03/2012, Volume 109, Issue 11, pp. 4058 - 4063
We report the results of an in vitro screening assay targeting the intraerythrocytic form of the malaria parasite Plasmodium falciparum using a library of 560... 
Molecules | Enzymes | Diphosphonates | Dimers | Diphosphates | Inhibitory concentration 50 | Parasitemia | Molecular chains | Crystal structure | Tunnels | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Plasmodium falciparum - enzymology | Plasmodium - enzymology | Humans | Imidazoles - chemistry | Crystallography, X-Ray | Parasitemia - drug therapy | Plasmodium - drug effects | Plasmodium falciparum - drug effects | Farnesyltranstransferase - metabolism | Terpenes - chemistry | Lipids - chemistry | Terpenes - metabolism | Enzyme Inhibitors - chemistry | Protein Binding - drug effects | Diphosphonates - therapeutic use | Farnesyltranstransferase - antagonists & inhibitors | Etidronic Acid - therapeutic use | Imidazoles - therapeutic use | Risedronate Sodium | Etidronic Acid - analogs & derivatives | Plasmodium vivax - enzymology | Plasmodium vivax - drug effects | Enzyme Inhibitors - pharmacology | Models, Molecular | Antimalarials - therapeutic use | Imidazoles - pharmacology | Antimalarials - pharmacology | Erythrocytes - drug effects | Farnesyltranstransferase - chemistry | Animals | Etidronic Acid - pharmacology | High-Throughput Screening Assays | Diphosphonates - chemistry | Antimalarials - chemistry | Survival Analysis | Parasitemia - parasitology | Calorimetry | Mice | Erythrocytes - parasitology | Etidronic Acid - chemistry | Diphosphonates - pharmacology | Risedronate | Microbiological chemistry | Plasmodium falciparum | Chemical properties | Research | Pyrophosphates | Index Medicus | Physical Sciences | calorimetry | crystallography | drug discovery | high-throughput screening
Journal Article
Journal Article